We are live on ! Find out more
USRD icon

Themes US R&D Champions ETF

1 hedge funds and large institutions have $1.23K invested in Themes US R&D Champions ETF in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.32% less ownership

Funds ownership: 4.44%0.13% (-4.3%)

50% less funds holding

Funds holding: 21 (-1)

97% less capital invested

Capital invested by funds: $36.8K → $1.23K (-$35.6K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$145

Top Sellers

Rank Fund Capital Flow
1
GWM
Geneos Wealth Management
Colorado
-$35.9K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1.23K +$145 +5 +15%
GWM
2
Geneos Wealth Management
Colorado
-$35.9K -1,300 Closed

USRD Hedge Fund Activity: Q2 2025 in Review

1 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Themes US R&D Champions ETF (USRD) for Q2 2025, worth a combined $1.23K — down 97% from $36.8K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of USRD and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $145. The largest seller was Geneos Wealth Management, exiting entirely with an estimated $35.9K sold.

  • 1 institutional investor held Themes US R&D Champions ETF (USRD) as of Q2 2025, down from 2 in Q1 2025.
  • Funds reported $1.23K of Themes US R&D Champions ETF stock for Q2 2025, down 97% quarter-over-quarter.
  • 0 funds opened new Themes US R&D Champions ETF positions in Q2 2025 and 1 closed out, a net change of -1 holder.
  • The largest Themes US R&D Champions ETF buyer in Q2 2025 was UBS Group, an estimated $145 added.
  • The largest Themes US R&D Champions ETF seller in Q2 2025 was Geneos Wealth Management, an estimated $35.9K sold.

Based on aggregated 13F filings for Q2 2025.